Clinical Trials Browser

INDUSTRY × Unilateral Breast Neoplasms × ribociclib × Clear all

NCT06760637 2026-03-02

FourLight-3

Phase 3 Recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence